Antibody-dependent passive protection of mucosal surfaces

0557460 - MBÚ 2023 RIV US eng J - Článek v odborném periodiku
Městecký, Jiří
Antibody-dependent passive protection of mucosal surfaces.
Human Vaccines & Immunotherapeutics. Roč. 18, č. 2 (2022), č. článku e1899549. ISSN 2164-5515. E-ISSN 2164-554X
Institucionální podpora: RVO:61388971
Klíčová slova: immunoglobulin-a * monomeric iga * serum iga * transport * virus * secretion * proteins * binding * cells * milk * Mucosal immunity * IgA * monoclonal antibodies * passive protection
Obor OECD: Microbiology
Impakt faktor: 4.8, rok: 2022
Způsob publikování: Open access
https://www.tandfonline.com/doi/full/10.1080/21645515.2021.1899549?scroll=top&needAccess=true

Extensive experiments performed mostly in a variety of animal models convincingly demonstrated the protective effect of polyclonal or monoclonal antibodies administered by the mucosal route. Because of the independence of the mucosal and systemic compartments of the immune system, antibodies from the circulation are not effectively transported in sufficient quantities into external secretions. Nevertheless, local application of antibodies of the desired specificity to mucosal membranes of the respiratory, gastrointestinal, and female genital tracts protected experimental animals from the subsequent challenge by corresponding viral or bacterial pathogens. Thus, generation of monoclonal antibodies of desired specificity and the selection of delivery systems to extend their otherwise short survival on some mucosal surfaces are essential aims of their usability in humans for the effective prevention of mucosally acquired infectious diseases.
Trvalý link: http://hdl.handle.net/11104/0331600